Regeneron Pharmaceuticals (REGN)

Add to Watchlists Create an Alert
254.87 -7.55  -2.88%   NASDAQ May 23, 8:00PM BATS Real time Currency in USD

Regeneron Pharmaceuticals Cash from Financing Quarterly:

11.52M for March 31, 2013
View Full Chart

Regeneron Pharmaceuticals Cash from Financing Quarterly Chart

    Regeneron Pharmaceuticals Historical Cash from Financing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 11.52M
    Dec. 31, 2012 -73.01M
    Sept. 30, 2012 -1.809M
    June 30, 2012 -5.077M
    March 31, 2012 -17.75M
    Dec. 31, 2011 361.44M
    Sept. 30, 2011 -0.279M
    June 30, 2011 10.05M
    March 31, 2011 13.04M
    Dec. 31, 2010 182.76M
    Sept. 30, 2010 1.613M
    June 30, 2010 2.719M
    March 31, 2010 56.22M
    Dec. 31, 2009 22.33M
    Sept. 30, 2009 2.148M
    June 30, 2009 0.667M
    March 31, 2009 6.22M
    Dec. 31, 2008 -115.72M
    Sept. 30, 2008 1.324M
    June 30, 2008 -80.37M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Cash From Financing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
    Learn More

    Get data for

    REGN Cash from Financing Quarterly Benchmarks

    Companies
    Sanofi
    Celgene Corporation -687.40M
    Exelixis -10.78M

    REGN Cash from Financing Quarterly Rankings

    Overall 90th percentile
    793 of 8006
    Sector 88th percentile
    81 of 686 in Healthcare
    Industry 85th percentile
    36 of 248 in Biotechnology

    REGN Cash from Financing Quarterly Range, Past 5 Years

    Minimum -115.72M Dec 2008
    Maximum 361.44M Dec 2011
    Average 18.90M